CVE-2024-25435

CVE-2024-25435 is a medium-severity vulnerability in Md1health Md1patient with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

A cross-site scripting (XSS) vulnerability in Md1health Md1patient v2.0.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the Msg parameter.

Frequently asked questions

What is CVE-2024-25435?
A cross-site scripting (XSS) vulnerability in Md1health Md1patient v2.0.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the Msg parameter.
How severe is CVE-2024-25435?
CVE-2024-25435 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2024-25435 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-25435?
CVE-2024-25435 primarily affects Md1health Md1patient. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2024-25435?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-25435 have an EU (EUVD) identifier?
Yes. CVE-2024-25435 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-22764.
When was CVE-2024-25435 published?
CVE-2024-25435 was published on 2024-02-28 and last updated on 2026-06-17.

References

Affected products (2)

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →